Covered recipient · General Payments record
ALEJANDRO TRUJILLO
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2019–2024
$538.17
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $239.56 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $98.18 | 5 |
| Lilly USA, LLC | $64.71 | 3 |
| Amgen Inc. | $43.96 | 3 |
| GlaxoSmithKline, LLC. | $18.91 | 1 |
| Acerta Pharma LLC | $13.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.03 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402348 | CMS |
| Amgen Inc. | $13.61 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402350 | CMS |
| Amgen Inc. | $15.32 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402352 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.80 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105700910 | CMS |
| GlaxoSmithKline, LLC. | $18.91 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116333853 | CMS |
| Lilly USA, LLC | $21.62 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136018105 | CMS |
| Lilly USA, LLC | $22.03 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136017117 | CMS |
| Lilly USA, LLC | $21.06 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136018381 | CMS |
| Novo Nordisk Inc | $17.37 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096883268 | CMS |
| Novo Nordisk Inc | $20.08 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097335430 | CMS |
| Novo Nordisk Inc | $21.75 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097414522 | CMS |
| Novo Nordisk Inc | $23.94 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096909755 | CMS |
| Novo Nordisk Inc | $15.04 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096896291 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.